Daniele Urzì

434 total citations
17 papers, 266 citations indexed

About

Daniele Urzì is a scholar working on Pulmonary and Respiratory Medicine, Urology and Rheumatology. According to data from OpenAlex, Daniele Urzì has authored 17 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Urology and 5 papers in Rheumatology. Recurrent topics in Daniele Urzì's work include Prostate Cancer Diagnosis and Treatment (8 papers), Urinary Bladder and Prostate Research (7 papers) and Hormonal and reproductive studies (4 papers). Daniele Urzì is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Urinary Bladder and Prostate Research (7 papers) and Hormonal and reproductive studies (4 papers). Daniele Urzì collaborates with scholars based in Italy, Belgium and Germany. Daniele Urzì's co-authors include Sebastiano Cimino, Giuseppe Morgia, Giorgio Ivan Russo, Salvatore Privitera, Vincenzo Favilla, Tommaso Castelli, Rosita A. Condorelli, Sandro La Vignera, Aldo E. Calogero and Giulio Reale and has published in prestigious journals such as British Journal of Urology, World Journal of Urology and Expert Opinion on Pharmacotherapy.

In The Last Decade

Daniele Urzì

17 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniele Urzì Italy 10 112 98 64 57 52 17 266
F. Debruyne Belgium 7 196 1.8× 188 1.9× 133 2.1× 37 0.6× 63 1.2× 19 357
Anna De Matteis Italy 7 192 1.7× 166 1.7× 107 1.7× 124 2.2× 79 1.5× 13 449
Zhitao Wei China 11 61 0.5× 105 1.1× 49 0.8× 96 1.7× 21 0.4× 29 319
L. Romis Italy 9 55 0.5× 178 1.8× 58 0.9× 89 1.6× 14 0.3× 17 329
Duk Yoon Kim South Korea 11 159 1.4× 67 0.7× 14 0.2× 175 3.1× 241 4.6× 35 415
Greg Jack Australia 5 191 1.7× 169 1.7× 14 0.2× 37 0.6× 135 2.6× 13 348
Yi‐Wei Lin China 10 20 0.2× 86 0.9× 25 0.4× 98 1.7× 20 0.4× 31 356
Po‐Fan Hsieh Taiwan 10 47 0.4× 159 1.6× 9 0.1× 58 1.0× 66 1.3× 39 312
G. Romanò Italy 8 30 0.3× 29 0.3× 78 1.2× 87 1.5× 11 0.2× 12 206
Benito Fabio Mirto Italy 6 30 0.3× 82 0.8× 11 0.2× 57 1.0× 19 0.4× 13 222

Countries citing papers authored by Daniele Urzì

Since Specialization
Citations

This map shows the geographic impact of Daniele Urzì's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Urzì with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Urzì more than expected).

Fields of papers citing papers by Daniele Urzì

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Urzì. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Urzì. The network helps show where Daniele Urzì may publish in the future.

Co-authorship network of co-authors of Daniele Urzì

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Urzì. A scholar is included among the top collaborators of Daniele Urzì based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Urzì. Daniele Urzì is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zanghì, Aurora, Sebastiano Cimino, Daniele Urzì, et al.. (2020). Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis patients. Expert Opinion on Pharmacotherapy. 21(12). 1449–1454. 11 indexed citations
2.
Veneziano, Domenico, Giuseppe Morgia, Sebastiano Cimino, et al.. (2020). Evaluation of the “Teaching Guide for Basic Laparoscopic Skills” as a stand-alone educational tool for hands-on training sessions: a pilot study. World Journal of Urology. 39(1). 281–287. 3 indexed citations
3.
Russo, Giorgio Ivan, Daniele Urzì, Salvatore Privitera, et al.. (2018). Adherence to Mediterranean diet and prostate cancer risk in Sicily: population-based case–control study. International Journal of Impotence Research. 31(4). 269–275. 26 indexed citations
4.
Russo, Giorgio Ivan, F. Regis, Pietro Spatafora, et al.. (2017). Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms ( MIPS Study). British Journal of Urology. 121(5). 799–804. 17 indexed citations
5.
Morgia, Giuseppe, Giorgio Ivan Russo, Daniele Urzì, et al.. (2017). A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III. Archivio Italiano di Urologia e Andrologia. 89(2). 110–110. 38 indexed citations
6.
Favilla, Vincenzo, Tommaso Castelli, Daniele Urzì, et al.. (2016). Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study. International braz j urol. 42(4). 685–693. 29 indexed citations
7.
Russo, Giorgio Ivan, Tommaso Castelli, Daniele Urzì, et al.. (2015). Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis. The Aging Male. 18(4). 207–216. 30 indexed citations
8.
Russo, Giorgio Ivan, Tommaso Castelli, Vincenzo Favilla, et al.. (2015). Performance of biopsy factors in predicting unfavorable disease in patients eligible for active surveillance according to the PRIAS criteria. Prostate Cancer and Prostatic Diseases. 18(4). 338–342. 5 indexed citations
9.
Russo, Giorgio Ivan, Luca Vanella, Tommaso Castelli, et al.. (2015). Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients. World Journal of Urology. 34(8). 1183–1192. 13 indexed citations
10.
Russo, Giorgio Ivan, Tommaso Castelli, Salvatore Privitera, et al.. (2015). Increase of Framingham risk score is associated with severity of Lower urinary tract symptoms.. 1 indexed citations
11.
Russo, Giorgio Ivan, Tommaso Castelli, Salvatore Privitera, et al.. (2015). Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms. British Journal of Urology. 116(5). 791–796. 26 indexed citations
12.
Russo, Giorgio Ivan, Tommaso Castelli, Daniele Urzì, et al.. (2015). Emerging links between non‐neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review. International Journal of Urology. 22(11). 982–990. 32 indexed citations
13.
Favilla, Vincenzo, Giorgio Ivan Russo, Daniele Urzì, et al.. (2014). Prevalence of Intratubular Germ Cell Neoplasia and Multifocality in Testicular Germ Cell Tumors ≤ 2 cm: Relationship With Other Pathological Features. Clinical Genitourinary Cancer. 13(1). e31–e35. 3 indexed citations
14.
Morgia, Giuseppe, Daniele Urzì, & Giorgio Ivan Russo. (2014). 5ARIs and PSA: Evidences. Urologia Journal. 81(24_suppl). 4–11. 2 indexed citations
15.
16.
Favilla, Vincenzo, Giorgio Ivan Russo, Daniele Urzì, et al.. (2013). Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?. International Urology and Nephrology. 46(6). 1131–5. 7 indexed citations
17.
Russo, Giorgio Ivan, Sebastiano Cimino, Tommaso Castelli, et al.. (2013). Percentage of cancer involvement in positive cores can predict unfavorable disease in men with low-risk prostate cancer but eligible for the prostate cancer international: Active surveillance criteria. Urologic Oncology Seminars and Original Investigations. 32(3). 291–296. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026